vs
Fortress Biotech, Inc.（FBIO）与Rumble Inc.（RUM）财务数据对比。点击上方公司名可切换其他公司
Rumble Inc.的季度营收约是Fortress Biotech, Inc.的1.7倍（$27.1M vs $16.1M），Fortress Biotech, Inc.净利率更高（-24.5% vs -120.8%，领先96.3%），Fortress Biotech, Inc.同比增速更快（6.3% vs -10.5%），过去两年Rumble Inc.的营收复合增速更高（15.2% vs 11.0%）
堡垒生物科技（Fortress Biotech）是一家生物制药企业，核心业务为收购、开发并商业化创新医药与生物技术产品。公司由医学博士林赛·A·罗森瓦尔德担任首席执行官，包括绝大多数子公司在内，公司总部均设于佛罗里达州贝港群岛。
Rumble Inc.是一家加美跨国企业，主营在线视频平台、网络托管及云服务，总部位于加拿大多伦多，美国总部设在佛罗里达州朗博特基。公司由加拿大科技创业者克里斯·帕夫洛夫斯基于2013年创立，云服务板块为Truth Social提供托管支持，其视频平台在美国保守派及极右翼用户群体中广受欢迎，属于“另类科技”阵营。
FBIO vs RUM — 直观对比
营收规模更大
RUM
是对方的1.7倍
$16.1M
营收增速更快
FBIO
高出16.7%
-10.5%
净利率更高
FBIO
高出96.3%
-120.8%
两年增速更快
RUM
近两年复合增速
11.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.1M | $27.1M |
| 净利润 | $-3.9M | $-32.7M |
| 毛利率 | 66.1% | 5.5% |
| 营业利润率 | -28.8% | -131.1% |
| 净利率 | -24.5% | -120.8% |
| 营收同比 | 6.3% | -10.5% |
| 净利润同比 | 41.8% | 86.2% |
| 每股收益（稀释后） | $-0.15 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FBIORUM
| Q4 25 | $16.1M | $27.1M | ||
| Q3 25 | $17.6M | $24.8M | ||
| Q2 25 | $16.4M | — | ||
| Q1 25 | $13.1M | $23.7M | ||
| Q4 24 | $15.1M | $30.2M | ||
| Q3 24 | $14.6M | $25.1M | ||
| Q2 24 | $14.9M | $22.5M | ||
| Q1 24 | $13.0M | $17.7M |
净利润FBIORUM
| Q4 25 | $-3.9M | $-32.7M | ||
| Q3 25 | $5.8M | $-16.3M | ||
| Q2 25 | $15.5M | — | ||
| Q1 25 | $-10.6M | $-2.7M | ||
| Q4 24 | $-6.8M | $-236.8M | ||
| Q3 24 | $-12.9M | $-31.5M | ||
| Q2 24 | $-10.9M | $-26.8M | ||
| Q1 24 | $-15.4M | $-43.3M |
毛利率FBIORUM
| Q4 25 | 66.1% | 5.5% | ||
| Q3 25 | 67.4% | -1.8% | ||
| Q2 25 | 69.9% | — | ||
| Q1 25 | 63.5% | -26.7% | ||
| Q4 24 | 69.1% | -14.2% | ||
| Q3 24 | 69.4% | -45.4% | ||
| Q2 24 | 61.6% | -58.8% | ||
| Q1 24 | 53.9% | -79.5% |
营业利润率FBIORUM
| Q4 25 | -28.8% | -131.1% | ||
| Q3 25 | -38.6% | -113.6% | ||
| Q2 25 | -222.2% | — | ||
| Q1 25 | -169.9% | -153.5% | ||
| Q4 24 | -158.3% | -80.1% | ||
| Q3 24 | -151.0% | -131.0% | ||
| Q2 24 | -186.5% | -172.7% | ||
| Q1 24 | -280.6% | -197.4% |
净利率FBIORUM
| Q4 25 | -24.5% | -120.8% | ||
| Q3 25 | 33.2% | -65.7% | ||
| Q2 25 | 94.4% | — | ||
| Q1 25 | -80.6% | -11.2% | ||
| Q4 24 | -44.7% | -783.2% | ||
| Q3 24 | -88.0% | -125.9% | ||
| Q2 24 | -73.5% | -119.2% | ||
| Q1 24 | -118.3% | -244.1% |
每股收益（稀释后）FBIORUM
| Q4 25 | $-0.15 | $-0.13 | ||
| Q3 25 | $0.11 | $-0.06 | ||
| Q2 25 | $0.45 | — | ||
| Q1 25 | $-0.48 | $-0.01 | ||
| Q4 24 | $-0.16 | $-1.17 | ||
| Q3 24 | $-0.76 | $-0.15 | ||
| Q2 24 | $-0.73 | $-0.13 | ||
| Q1 24 | $-1.04 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $79.4M | $237.9M |
| 总债务越低越好 | $52.4M | — |
| 股东权益账面价值 | $49.9M | $274.8M |
| 总资产 | $185.5M | $336.8M |
| 负债/权益比越低杠杆越低 | 1.05× | — |
8季度趋势，按日历期对齐
现金及短期投资FBIORUM
| Q4 25 | $79.4M | $237.9M | ||
| Q3 25 | $86.2M | $269.8M | ||
| Q2 25 | $74.4M | — | ||
| Q1 25 | $91.3M | $301.3M | ||
| Q4 24 | $57.3M | $114.0M | ||
| Q3 24 | $58.9M | $132.0M | ||
| Q2 24 | $76.2M | $154.2M | ||
| Q1 24 | $83.8M | $183.8M |
总债务FBIORUM
| Q4 25 | $52.4M | — | ||
| Q3 25 | $47.8M | — | ||
| Q2 25 | $50.0M | — | ||
| Q1 25 | $56.4M | — | ||
| Q4 24 | $58.0M | — | ||
| Q3 24 | $52.5M | — | ||
| Q2 24 | $67.0M | — | ||
| Q1 24 | $61.4M | — |
股东权益FBIORUM
| Q4 25 | $49.9M | $274.8M | ||
| Q3 25 | $55.9M | $302.2M | ||
| Q2 25 | $43.9M | — | ||
| Q1 25 | $22.3M | $339.6M | ||
| Q4 24 | $22.7M | $-63.1M | ||
| Q3 24 | $21.2M | $166.1M | ||
| Q2 24 | $17.9M | $192.7M | ||
| Q1 24 | $23.0M | $210.7M |
总资产FBIORUM
| Q4 25 | $185.5M | $336.8M | ||
| Q3 25 | $181.4M | $367.2M | ||
| Q2 25 | $159.9M | — | ||
| Q1 25 | $178.1M | $391.1M | ||
| Q4 24 | $144.2M | $195.3M | ||
| Q3 24 | $127.1M | $217.2M | ||
| Q2 24 | $145.7M | $243.2M | ||
| Q1 24 | $164.6M | $263.0M |
负债/权益比FBIORUM
| Q4 25 | 1.05× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 2.53× | — | ||
| Q4 24 | 2.55× | — | ||
| Q3 24 | 2.48× | — | ||
| Q2 24 | 3.75× | — | ||
| Q1 24 | 2.67× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-12.5M | $-29.4M |
| 自由现金流经营现金流 - 资本支出 | — | $-31.7M |
| 自由现金流率自由现金流/营收 | — | -117.2% |
| 资本支出强度资本支出/营收 | — | 8.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-70.8M |
8季度趋势，按日历期对齐
经营现金流FBIORUM
| Q4 25 | $-12.5M | $-29.4M | ||
| Q3 25 | $-6.1M | $-10.6M | ||
| Q2 25 | $-27.6M | — | ||
| Q1 25 | $-19.6M | $-14.5M | ||
| Q4 24 | $-12.9M | $-12.4M | ||
| Q3 24 | $-20.1M | $-19.1M | ||
| Q2 24 | $-21.8M | $-21.7M | ||
| Q1 24 | $-25.4M | $-33.9M |
自由现金流FBIORUM
| Q4 25 | — | $-31.7M | ||
| Q3 25 | — | $-12.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-14.6M | ||
| Q4 24 | — | $-12.4M | ||
| Q3 24 | — | $-19.9M | ||
| Q2 24 | — | $-23.1M | ||
| Q1 24 | — | $-34.3M |
自由现金流率FBIORUM
| Q4 25 | — | -117.2% | ||
| Q3 25 | — | -48.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -61.7% | ||
| Q4 24 | — | -40.9% | ||
| Q3 24 | — | -79.5% | ||
| Q2 24 | — | -102.8% | ||
| Q1 24 | — | -193.3% |
资本支出强度FBIORUM
| Q4 25 | — | 8.5% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 0.0% | 3.4% | ||
| Q2 24 | — | 6.1% | ||
| Q1 24 | — | 2.4% |
现金转化率FBIORUM
| Q4 25 | — | — | ||
| Q3 25 | -1.04× | — | ||
| Q2 25 | -1.78× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FBIO
暂无分部数据
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
